195 related articles for article (PubMed ID: 25095753)
1. Low yield of chemical shift MRI for characterization of adrenal lesions with high attenuation density on unenhanced CT.
Sebro R; Aslam R; Muglia VF; Wang ZJ; Westphalen AC
Abdom Imaging; 2015 Feb; 40(2):318-26. PubMed ID: 25095753
[TBL] [Abstract][Full Text] [Related]
2. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas.
Israel GM; Korobkin M; Wang C; Hecht EN; Krinsky GA
AJR Am J Roentgenol; 2004 Jul; 183(1):215-9. PubMed ID: 15208141
[TBL] [Abstract][Full Text] [Related]
3. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
[TBL] [Abstract][Full Text] [Related]
4. Characterization of adrenal adenomas and metastases: correlation between unenhanced computed tomography and chemical shift magnetic resonance imaging.
Rescinito G; Zandrino F; Cittadini G; Santacroce E; Giasotto V; Neumaier CE
Acta Radiol; 2006 Feb; 47(1):71-6. PubMed ID: 16498936
[TBL] [Abstract][Full Text] [Related]
5. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT.
Seo JM; Park BK; Park SY; Kim CK
AJR Am J Roentgenol; 2014 May; 202(5):1043-50. PubMed ID: 24758658
[TBL] [Abstract][Full Text] [Related]
6. Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules.
Jhaveri KS; Wong F; Ghai S; Haider MA
AJR Am J Roentgenol; 2006 Nov; 187(5):1303-8. PubMed ID: 17056920
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma.
Schieda N; Alrashed A; Flood TA; Samji K; Shabana W; McInnes MD
AJR Am J Roentgenol; 2016 Jun; 206(6):1141-8. PubMed ID: 27011100
[TBL] [Abstract][Full Text] [Related]
8. Adrenal masses: CT characterization with histogram analysis method.
Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
[TBL] [Abstract][Full Text] [Related]
9. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences.
Outwater EK; Siegelman ES; Huang AB; Birnbaum BA
Radiology; 1996 Sep; 200(3):749-52. PubMed ID: 8756926
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of 'Fat-Poor' Adrenal Adenomas at Chemical-Shift MRI.
Aldhufian M; Sheinis Pickovsky J; Alfaleh H; Melkus G; Schieda N
Can Assoc Radiol J; 2024 Feb; 75(1):98-106. PubMed ID: 37335612
[TBL] [Abstract][Full Text] [Related]
11. Can Texture Analysis Be Used to Distinguish Benign From Malignant Adrenal Nodules on Unenhanced CT, Contrast-Enhanced CT, or In-Phase and Opposed-Phase MRI?
Ho LM; Samei E; Mazurowski MA; Zheng Y; Allen BC; Nelson RC; Marin D
AJR Am J Roentgenol; 2019 Mar; 212(3):554-561. PubMed ID: 30620676
[TBL] [Abstract][Full Text] [Related]
12. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
Haider MA; Ghai S; Jhaveri K; Lockwood G
Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
[TBL] [Abstract][Full Text] [Related]
13. Determination of a cutoff attenuation value on single-phase contrast-enhanced CT for characterizing adrenal nodules via chemical shift MRI.
Wu YW; Tan CH
Abdom Radiol (NY); 2016 Jun; 41(6):1170-7. PubMed ID: 26830419
[TBL] [Abstract][Full Text] [Related]
14. Adrenal adenomas: relationship between histologic lipid and CT and MR findings.
Korobkin M; Giordano TJ; Brodeur FJ; Francis IR; Siegelman ES; Quint LE; Dunnick NR; Heiken JP; Wang HH
Radiology; 1996 Sep; 200(3):743-7. PubMed ID: 8756925
[TBL] [Abstract][Full Text] [Related]
15. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
Park BK; Kim CK; Kim B; Lee JH
Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of norcholesterol scintigraphy, CT attenuation value, and chemical-shift MR imaging for characterizing adrenal adenomas.
Yoh T; Hosono M; Komeya Y; Im SW; Ashikaga R; Shimono T; Tsuchiya N; Okada M; Hanada K; Yagyu Y; Nishimura Y; Murakami T
Ann Nucl Med; 2008 Jul; 22(6):513-9. PubMed ID: 18670858
[TBL] [Abstract][Full Text] [Related]
17. Unenhanced Dual-Layer Spectral-Detector CT for Characterizing Indeterminate Adrenal Lesions.
Nagayama Y; Inoue T; Oda S; Tanoue S; Nakaura T; Morinaga J; Ikeda O; Hirai T
Radiology; 2021 Nov; 301(2):369-378. PubMed ID: 34427466
[TBL] [Abstract][Full Text] [Related]
18. Chemical-shift MRI versus washout CT for characterizing adrenal incidentalomas.
Warda MH; Shehata SM; Zaiton F
Clin Imaging; 2016; 40(4):780-7. PubMed ID: 27317224
[TBL] [Abstract][Full Text] [Related]
19. Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.
Nagayama Y; Inoue T; Kato Y; Tanoue S; Kidoh M; Oda S; Nakaura T; Hirai T
Radiology; 2021 Nov; 301(2):360-368. PubMed ID: 34463552
[TBL] [Abstract][Full Text] [Related]
20. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
